Tian C - Search Results

1

The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy.

Xie X, Lv J, Zhu W, Tian C, Li J, Liu J, Zhou H, Sun C, Hu Z, Li X. Xie X, et al. Among authors: tian c. Transl Oncol. 2022 Jan;15(1):101287. doi: 10.1016/j.tranon.2021.101287. Epub 2021 Nov 19. Transl Oncol. 2022. PMID: 34808461 Free PMC article.

2

Enhanced anti-tumor response elicited by a novel oncolytic HSV-1 engineered with an anti-PD-1 antibody.

Tian C, Liu J, Zhou H, Li J, Sun C, Zhu W, Yin Y, Li X. Tian C, et al. Cancer Lett. 2021 Oct 10;518:49-58. doi: 10.1016/j.canlet.2021.06.005. Epub 2021 Jun 15. Cancer Lett. 2021. PMID: 34139284

3

The oncolytic virus VT09X optimizes immune checkpoint therapy in low immunogenic melanoma.

Zhu W, Lv J, Xie X, Tian C, Liu J, Zhou H, Sun C, Li J, Hu Z, Li X. Zhu W, et al. Among authors: tian c. Immunol Lett. 2022 Jan;241:15-22. doi: 10.1016/j.imlet.2021.11.002. Epub 2021 Nov 12. Immunol Lett. 2022. PMID: 34774916

4

Preclinical safety assessment of toxicity and biodistribution of oncolytic virus HSV-1 expressing human PD-1 antibody in mice.

Wang X, Wang C, Qu Z, Tian C, Wang T, Miao Y, Jiang H, Li L, Liu J, Zhao R, Li X, Geng X. Wang X, et al. Among authors: tian c. Regul Toxicol Pharmacol. 2022 Jul;132:105166. doi: 10.1016/j.yrtph.2022.105166. Epub 2022 Apr 9. Regul Toxicol Pharmacol. 2022. PMID: 35405296

5

Improved tolerance of maize plants to salt stress by arbuscular mycorrhiza is related to higher accumulation of soluble sugars in roots.

Feng G, Zhang FS, Li XL, Tian CY, Tang C, Rengel Z. Feng G, et al. Among authors: tian cy. Mycorrhiza. 2002 Aug;12(4):185-90. doi: 10.1007/s00572-002-0170-0. Epub 2002 May 1. Mycorrhiza. 2002. PMID: 12189473

6

[Evaluation of the relationship between the attachment type of lateral pterygoid muscle and the position of temporomandibular joint disc in patients with temporomandibular joint disorders based on wireless amplified MRI detector high resolution imaging].

Cheng XG, Tian C, Hu R, Liu J, Xu M, Wu Y, Wang RP, Zeng XC. Cheng XG, et al. Among authors: tian c. Zhonghua Kou Qiang Yi Xue Za Zhi. 2023 Jun 9;58(6):569-574. doi: 10.3760/cma.j.cn112144-20230418-00161. Zhonghua Kou Qiang Yi Xue Za Zhi. 2023. PMID: 37272002 Chinese.

7

Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas.

Ma J, Lang B, Wang L, Zhou Y, Fu C, Tian C, Xue L. Ma J, et al. Among authors: tian c. Mol Biotechnol. 2024 Jun 5. doi: 10.1007/s12033-024-01197-4. Online ahead of print. Mol Biotechnol. 2024. PMID: 38836983

8

Frontal-Variant Alzheimer's Disease: Subregional Distribution of Entorhinal-CA1 Pathology and Pathophysiological Implications.

Reyes I, Faustin A, Tian C, Masurkar AV. Reyes I, et al. Among authors: tian c. J Neuropsychiatry Clin Neurosci. 2024 Jun 5:appineuropsych20230113. doi: 10.1176/appi.neuropsych.20230113. Online ahead of print. J Neuropsychiatry Clin Neurosci. 2024. PMID: 38835223 No abstract available.

9

Nitrogen Removal Performance and Microbial Community Structure of IMTA Ponds (Apostistius japonicus-Penaeus japonicus-Ulva).

Chen D, Tian C, Yuan H, Zhai W, Chang Z. Chen D, et al. Among authors: tian c. Microb Ecol. 2024 Jun 3;87(1):82. doi: 10.1007/s00248-024-02378-z. Microb Ecol. 2024. PMID: 38831142 Free PMC article.

10

GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy.

Tian C, Zhang H, Liu J, Xu M, Ma L. Tian C, et al. Front Pharmacol. 2024 May 17;15:1396133. doi: 10.3389/fphar.2024.1396133. eCollection 2024. Front Pharmacol. 2024. PMID: 38828460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,563 results

Search Page